rs80338853
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(C;C) | 0 | common in clinvar |
(C;T) | 3 | Unaffected carrier of a Smith-Lemli-Opitz syndrome mutation |
Make rs80338853(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 11 |
Position | 71444036 |
Gene | DHCR7 |
is a | snp |
is | mentioned by |
dbSNP | rs80338853 |
dbSNP (classic) | rs80338853 |
ClinGen | rs80338853 |
ebi | rs80338853 |
HLI | rs80338853 |
Exac | rs80338853 |
Gnomad | rs80338853 |
Varsome | rs80338853 |
LitVar | rs80338853 |
Map | rs80338853 |
PheGenI | rs80338853 |
Biobank | rs80338853 |
1000 genomes | rs80338853 |
hgdp | rs80338853 |
ensembl | rs80338853 |
geneview | rs80338853 |
scholar | rs80338853 |
rs80338853 | |
pharmgkb | rs80338853 |
gwascentral | rs80338853 |
openSNP | rs80338853 |
23andMe | rs80338853 |
SNPshot | rs80338853 |
SNPdbe | rs80338853 |
MSV3d | rs80338853 |
GWAS Ctlg | rs80338853 |
Max Magnitude | 3 |
ClinVar | |
---|---|
Risk | rs80338853(T;T) |
Alt | rs80338853(T;T) |
Reference | Rs80338853(C;C) |
Significance | Pathogenic |
Disease | Smith-Lemli-Opitz syndrome not provided Abnormality of brain morphology |
Variation | info |
Gene | DHCR7 |
CLNDBN | Smith-Lemli-Opitz syndrome not provided Abnormality of brain morphology |
Reversed | 1 |
HGVS | NC_000011.9:g.71155082G>A |
CLNSRC | HGMD OMIM Allelic Variant UniProtKB (protein) |
CLNACC | RCV000007185.4, RCV000079651.4, RCV000454251.1, |
[PMID 162072] Physiotherapy in certain aspects of psychosomatic medicine.
[PMID 9653161] Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome.
[PMID 10602371] Smith-Lemli-Opitz syndrome: evidence of T93M as a common mutation of delta7-sterol reductase in Italy and report of three novel mutations.
[PMID 11175299] Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations.
[PMID 15952211] DHCR7 mutations in Brazilian Smith-Lemli-Opitz syndrome patients.
[PMID 17965227] Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations.